BWA
NUVB icon

Basecamp Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

Basecamp Wealth Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112
Closed -$480 – 1939
2026
Q1 		$480 Buy
+112
New +$624 ﹤0.01% 1740

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Basecamp Wealth Advisors's NUVB Position: Q2 2026 in Review

Basecamp Wealth Advisors sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 112 shares — an estimated $480 sold.

Basecamp Wealth Advisors first reported a position in NUVB in Q1 2026 and held it in 1 quarter. The position peaked at $480 in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Basecamp Wealth Advisors reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 112 Nuvation Bio shares in Q2 2026, an estimated $480.
  • Basecamp Wealth Advisors first reported a position in Nuvation Bio in Q1 2026 and held it in 1 quarter.
  • Basecamp Wealth Advisors's Nuvation Bio position peaked at $480 in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.